Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582810 · ClinicalTrials.gov registry record
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
A clinical trial of Headache and Subarachnoid; Hemorrhage, Nontraumatic, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06582810: Recruiting study of Headache and Subarachnoid; Hemorrhage, Nontraumatic, sponsored by University of Kansas Medical Center.
NCT06582810 is a study of Headache and Subarachnoid; Hemorrhage, Nontraumatic that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 20 participants, below the 155-participant average among 35 other Headache trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06582810, a study of Headache and Subarachnoid; Hemorrhage, Nontraumatic, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort. Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.
Primary Outcome
Reduction of pain ≥ 2 points in the numeric pain score after lidocaine infusion treatment. The numeric pain score is a score rating severity of pain from 0 to 10, with higher scores meaning worse pain. The reduction in pain scores indicates a decrease in severity of pain.
Conditions Studied
Study Locations (1)
Kansas
- Ascension Via Christi St. Francis - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2028-07 |
What NCT06582810 shows while recruiting
NCT06582810 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 155-participant average among 35 other Headache trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 0 interventions.
NCT06582810 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06582810 about?
NCT06582810 is a clinical study titled "Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches". The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significa...
What is the current status of trial NCT06582810?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-01-31. Estimated completion is 2028-07.
What conditions does trial NCT06582810 study?
This clinical trial studies the following conditions: Headache, Subarachnoid; Hemorrhage, Nontraumatic.
Who is sponsoring clinical trial NCT06582810?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06582810 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06582810's enrollment target sits among peer trials
20 32nd of 35 higher than 2 of 35 other Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Puberty, Testosterone, and Brain Development
RECRUITING
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI